Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]-

Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354;
Email: support@targetmol.com

Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- manufacturers

  • VU0652925
  • VU0652925 pictures
  • $2980.00
  • 2026-07-27
  • CAS:1476847-58-1
  • Purity:
  • Supply Ability: 10g
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- Basic information
Product Name:Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]-
Synonyms:Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]-;VU 0652925;VU0652925;VU-0652925
CAS:1476847-58-1
MF:C24H18N4O4S2
MW:490.55
EINECS:
Product Categories:
Mol File:1476847-58-1.mol
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- Structure
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- Chemical Properties
density 1.50±0.1 g/cm3(Predicted)
pka0.55±0.10(Predicted)
Safety Information
MSDS Information
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- Usage And Synthesis
DescriptionVU0652925 is a PAR4 antagonist. VU0652925 had a PAC1 IC50 of 43.0 pM (-pIC50±SEM: 10.4±0.04) and a P-sel IC50 of 39.2 pM (-pIC50±SEM: 10.41±0.04). PAR4 antagonists is potential useful for the development of tools such as radioligands and PET tracers that are not currently available to the field for this target.
UsesVU0652925, an analog of BMS986120, is a PAR4 antagonist, with IC50 values of 43 pM and 39.2 pM for PAC1 and P-selectin, respectively. VU0652925 is able to suppress GPIIbIIIa activation[1].
References[1] Matthew T Duvernay, et al. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets. Mol Pharmacol. 2017 Jan;91(1):39-47. DOI:10.1124/mol.116.106666
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]- Preparation Products And Raw materials
Tag:Imidazo[2,1-b]-1,3,4-thiadiazole, 2-methoxy-6-[6-methoxy-4-[(2-phenyl-4-thiazolyl)methoxy]-2-benzofuranyl]-(1476847-58-1) Related Product Information
VU 0463841 [Hexahydro-5-(4-pyridinyl)pyrrolo[3,4-c]pyrrol-2(1H)-yl][1-(5-isoquinolinylsulfonyl)-3-azetidinyl]-Methanone N-(5-chloro-2-methoxyphenyl)-2-[4-(4-methylpiperidin-1-yl)sulfonylpiperazin-1-yl]acetamide VU0453595 VU 0364439 5-[1-(2-ethoxyphenyl)sulfonylazetidin-3-yl]-3-thiophen-3-yl-1,2,4-oxadiazole VU 0360223 2(5H)-Furanone, 3-(3-fluorophenyl)-4-(4-methoxyphenyl)- VU 0360172 cyclopentyl 1,6-dimethyl-4-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide (1R,2R)-N-([S]-1-{4-[5-broMo-2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxaMide Urea, N-(3,4-difluorophenyl)-N'-[3-methyl-1-(phenylmethyl)-1H-pyrazol-5-yl]- VU-0486321 VU0238441 VU0483605 VU0453379 VU0810464